STAGE II LIP AND ORAL CAVITY CANCER AJCC V8
Clinical trials for STAGE II LIP AND ORAL CAVITY CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II LIP AND ORAL CAVITY CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II LIP AND ORAL CAVITY CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy before surgery may boost cancer fight in head and neck patients
Disease control Recruiting nowThis study is for people with head and neck cancer that has come back or not gone away. It tests if adding chemotherapy or a chemo-immunotherapy combination before standard salvage surgery can improve outcomes. About 180 participants will receive either chemo or chemo-immunothera…
Matched conditions: STAGE II LIP AND ORAL CAVITY CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:02 UTC
-
Could a smaller surgery spare oral cancer patients from shoulder problems?
Disease control Recruiting nowThis study tests if a less invasive procedure called sentinel lymph node biopsy works as well as the standard neck dissection for early-stage oral cavity cancer. The sentinel biopsy removes only a few key lymph nodes, which may reduce side effects like shoulder pain and stiffness…
Matched conditions: STAGE II LIP AND ORAL CAVITY CANCER AJCC V8
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
New drug aims to ease painful mouth sores for head and neck cancer patients
Symptom relief Recruiting nowThis study tests if adding BMX-001 to standard care can reduce severe mouth sores caused by chemoradiation in head and neck cancer patients. About 98 adults will receive either BMX-001 or a placebo alongside their usual treatment. The goal is to see if BMX-001 helps prevent painf…
Matched conditions: STAGE II LIP AND ORAL CAVITY CANCER AJCC V8
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC